Trial
NCT01352312
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
GlaxoSmithKline; Novartis
Condition
Chronic Lymphocytic Leukemia
Intervention
Bendamustine
Why stopped
Insufficient accrual over 12 mo period
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-29